Vaxtex Cotfab Ltd Valuation Improves Amidst Mixed Market Performance

Valuation Metrics and Recent Changes

As of 2 July 2026, Vaxtex Cotfab's price-to-earnings (P/E) ratio stands at a low 4.29, signalling a potentially undervalued stock compared to industry standards. The price-to-book value (P/BV) ratio is 1.06, indicating the stock is trading close to its book value, which is often considered a fair valuation level. These metrics have contributed to the company’s valuation grade improving from very attractive to attractive, suggesting a modest re-rating by the market.

However, the enterprise value to EBITDA (EV/EBITDA) ratio is relatively elevated at 14.57, which is higher than some peers, reflecting a more expensive operational valuation. The EV to EBIT ratio is similarly high at 14.72, while the EV to capital employed ratio remains low at 1.05, indicating efficient capital utilisation. The PEG ratio is exceptionally low at 0.01, which typically signals undervaluation relative to earnings growth, although this figure may be influenced by minimal expected growth or accounting nuances.

Comparative Peer Analysis

When compared with key competitors in the Garments & Apparels sector, Vaxtex Cotfab’s valuation stands out as attractive. For instance, Sportking India trades at a P/E of 18.62 and EV/EBITDA of 9.41, while Sumeet Industries is priced expensively with a P/E of 64.83 and EV/EBITDA of 38.1. Other peers such as SBC Exports and Pashupati Cotsp. are classified as very expensive, with P/E ratios exceeding 50 and EV/EBITDA multiples well above 50. In contrast, Vaxtex Cotfab’s modest multiples suggest a valuation discount relative to the sector.

Interestingly, some companies like Indo Rama Synthetic and Himatsingka Seide are rated very attractive with P/E ratios of 7.68 and 18.41 respectively, and EV/EBITDA multiples below 11, indicating that while Vaxtex Cotfab is attractively valued, there are peers with even more compelling valuations.

Financial Performance and Returns

Vaxtex Cotfab’s return on capital employed (ROCE) is 7.12%, which is moderate but not outstanding, while return on equity (ROE) is a robust 24.63%, signalling efficient equity utilisation. These figures suggest the company generates reasonable profitability, though operational efficiency could be improved.

Stock price performance has been volatile. The current price is ₹1.29, down 5.84% on the day, with a 52-week high of ₹2.66 and a low of ₹0.80. Year-to-date, the stock has declined by 37.07%, significantly underperforming the Sensex’s 8.13% loss over the same period. Over one year, however, the stock has gained 44.94%, outperforming the Sensex’s 6.01% decline. Longer-term returns are less favourable, with a 3-year loss of 42.67% and a 5-year loss of 65.14%, contrasting sharply with the Sensex’s strong gains over those periods.

Market Capitalisation and Grade Evolution

Vaxtex Cotfab is classified as a micro-cap stock, which inherently carries higher volatility and risk compared to larger peers. Its MarketsMOJO Mojo Score currently stands at 34.0, with a Mojo Grade of Sell, upgraded from a previous Strong Sell on 19 May 2026. This upgrade reflects some improvement in valuation attractiveness and possibly operational metrics, but the overall sentiment remains cautious.

The downgrade from Strong Sell to Sell suggests that while the stock is no longer viewed as severely undervalued or distressed, significant risks remain. Investors should weigh the company’s valuation appeal against its volatile price history and sector challenges.

Price Attractiveness in Context

The shift from very attractive to attractive valuation grade indicates a subtle market reassessment. The low P/E and P/BV ratios relative to peers suggest the stock remains undervalued on a fundamental basis. However, the elevated EV/EBITDA multiple and mixed return profile temper enthusiasm. The company’s operational profitability, as indicated by ROE and ROCE, is respectable but not compelling enough to drive a strong re-rating.

Investors should also consider the stock’s recent price volatility and underperformance against the Sensex over medium to long-term horizons. The 5.84% drop on the latest trading day underscores ongoing market uncertainty.

Investor Takeaway

Vaxtex Cotfab Ltd’s valuation metrics present a mixed picture. The company’s low P/E and P/BV ratios relative to peers and its sector suggest it remains attractively priced on a fundamental basis. However, the elevated EV/EBITDA multiple and modest ROCE indicate operational challenges that may limit upside potential.

Price performance has been inconsistent, with significant underperformance over the past three and five years, though recent one-year returns have been strong. The upgrade in Mojo Grade from Strong Sell to Sell reflects cautious optimism but also highlights persistent risks associated with micro-cap stocks in a competitive garments and apparels sector.

Investors should carefully balance the valuation appeal against the company’s financial and market risks. Comparing Vaxtex Cotfab with peers such as Indo Rama Synthetic and Himatsingka Seide, which offer very attractive valuations and stronger operational metrics, may provide better opportunities within the sector.

Overall, while the shift in valuation grade signals some improvement in price attractiveness, Vaxtex Cotfab remains a speculative investment requiring thorough due diligence and risk tolerance.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →